argenx SE (argenx SE) 3-Year Revenue Growth Rate : 197.50% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is argenx SE 3-Year Revenue Growth Rate?

argenx SE's Revenue per Share for the three months ended in Dec. 2023 was $6.88.

During the past 12 months, argenx SE's average Revenue per Share Growth Rate was 175.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 197.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 96.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 48.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of argenx SE was 197.50% per year. The lowest was -20.70% per year. And the median was 58.85% per year.

Competitive Comparison of argenx SE's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, argenx SE's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

argenx SE's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where argenx SE's 3-Year Revenue Growth Rate falls into.

argenx SE 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

argenx SE (NAS:ARGX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

argenx SE 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of argenx SE's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

argenx SE (argenx SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

ARGX:Mexico ARGXb:UK 0QW0:UK 1AEA:Germany 1AE:Germany 1AE:Germany A1RG34:Brazil ARGX:Belgium ARGX:Austria

Address

Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB

Website

https://www.argenx.com

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.